Back to search

Netherlands· NL-85e02ecc5e64

Abacavir/Lamivudine Accord 600 mg/300 mg, filmomhulde tabletten

A lamivudine and abacavir product containing abacavir + lamivudine 0-water, registered in Netherlands by Accord Healthcare B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC J05AR02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAbacavir/Lamivudine Accord 600 mg/300…ATCJ05AR02REGISTER NO.NL-85e02ecc5e64PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Lamivudine and abacavir is registered in 14 of 19 countries.

Countries holding a registration under ATC J05AR02 (lamivudine and abacavir), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Lamivudine and abacavir · ATC J05AR02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ABACAVIR + LAMIVUDINE 0-WATER
Manufacturer
Accord Healthcare B.V.
Country
Netherlands (NL)
ATC code
J05AR02
ATC class
Lamivudine and abacavir
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    117314

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for lamivudine and abacavir.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lamivudine and abacavir · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Lamivudine and abacavir in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lamivudine and abacavir products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Abacavir/Lamivudin Ratiopharm, Abacavir/Lamivudin Sandoz
  • Belgium · Abacavir/Lamivudine Viatris
  • Bulgaria · Abacavir/Lamivudine Viatris, Абакавир/Ламивудин Майлан
  • Cyprus · Kivala
  • Germany · Abacavir/Lamivudin Al, Abacavir/Lamivudin Aurobindo
  • Denmark · Abacavir/Lamivudin Medical Valley, Abacavir/Lamivudin Mylan
  • Estonia · Abacavir/Lamivudine Auxilia, Abacavir/Lamivudine Mylan
  • Spain · Abacavir/Lamivudina Aurovitas, Abacavir/Lamivudina Dr. Reddys
  • Finland · Abacavir/Lamivudin Mylan, Abacavir/Lamivudin Viatris
  • France · Abacavir / Lamivudine Biogaran, Abacavir/Lamivudine Arrow
  • United Kingdom (Northern Ireland) · Abacavir/Lamivudin Sandoz, Abacavir/Lamivudine Accord
  • Greece · Abacavir+lamivudine Mylan Pharma, Varistren
  • Hungary · Abacavir/Lamivudine Teva
  • Ireland · Abacavir/Lamivudine Mylan, Abacavir/Lamivudine Viatris
  • Iceland · Kivexa
  • Italy · Abacavir E Lamivudina Aurobindo, Abacavir E Lamivudina Sun
  • Liechtenstein · Kivexa
  • Lithuania · Abacavir / Lamivudine Auxilia, Abacavir/Lamivudine Accord
  • Luxembourg · Abacavir/Lamivudine Viatris
  • Latvia · Abacavir/Lamivudine Accord, Abacavir/Lamivudine Mylan
  • Norway · Abacavir/Lamivudin Mylan, Abacavir/Lamivudine Viatris
  • Poland · Abacavir + Lamivudine Sandoz
  • Portugal · Abacavir + Lamivudina Aurovitas, Abacavir + Lamivudina Farmoz
  • Romania · Abacavir/Lamivudină, Abacavir/Lamivudină Mylan
  • Sweden · Abacavir/Lamivudine Accord, Abacavir/Lamivudine Glenmark

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/78e71c30-6a9d-42ba-b299-bd58ccb5b777
GET /v1/drugs/78e71c30-6a9d-42ba-b299-bd58ccb5b777?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h117314_smpc_en.pdf",
  "strength": null,
  "atc_label": "Lamivudine And Abacavir",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg117314",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "MACROGOL 400",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "POVIDON K 90 (E 1201)",
    "TITAANDIOXIDE (E 171)",
    "ZONNEGEEL FCF ALUMINIUMLAK (E 110)"
  ],
  "substances": [
    "ABACAVIR",
    "LAMIVUDINE 0-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h117314_piluk.pdf",
  "authorised_at": "2016/04/07",
  "procedure_number": "NL/H/3488/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "117314",
  "additional_monitoring": "N"
}

See everything about lamivudine and abacavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.